Senti Biosciences, Inc.
SNTI
$2.08
-$0.02-0.95%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 37.21% | -31.51% | -16.52% | 96.74% | -93.43% |
| Total Depreciation and Amortization | -4.44% | -5.87% | -5.89% | -1.02% | -47.88% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -90.58% | 251.94% | 205.61% | -405.26% | 1,075.83% |
| Change in Net Operating Assets | 73.79% | -128.08% | -453.50% | -124.39% | 714.41% |
| Cash from Operations | -20.09% | -56.66% | -20.27% | -91.90% | 48.85% |
| Capital Expenditure | -- | -- | -- | -175.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -100.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -100.00% | -- | -- | -110.89% | -99.72% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,260.00% | -- | -- | 8,371.33% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.49% | -- | -- | -- | -- |
| Cash from Financing | -94.92% | -- | -- | 9,124.82% | 10,708.70% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -73.72% | -46.75% | -23.66% | 692.08% | -193.48% |